Genetic Testing and Results in a Population-Based Cohort of Breast Cancer Patients and Ovarian Cancer Patients

Kurian et al. (Tue,) studied this question.

www.synapsesocial.com/papers/69d73537779571b57e48f4ec — DOI: https://doi.org/10.1200/jco.18.01854

Also consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. Characteristics of Triple-Negative Breast Cancer in Patients With a <i>BRCA1</i> Mutation: Results From a Population-Based Study of Young Women· 2011 · 125 citations
2. Population-Based Genetic Testing for <i>BRCA1</i> and <i>BRCA2</i>· 2018 · 5 citations
3. Low-penetrance susceptibility to breast cancer due to CHEK2*1100delC in noncarriers of BRCA1 or BRCA2 mutations· 2002 · 1,107 citations
4. Niraparib: First Global Approval· 2017 · 175 citations
5. Breast-Cancer Risk in Families with Mutations in <i>PALB2</i>· 2014 · 852 citations